1 unknown, 1 withdrawn. 1 Early Phase 1, 1 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Early Phase 1 | 1 | Withdrawn 1 |
| Phase 2 | 1 | Unknown 1 |
| Phase 3 | 1 | Unknown 1 |
Follow Serous Adenocarcinoma: new trials by email Literature Review of Serous Adenocarcinoma trials Research Report on Serous Adenocarcinoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Niraparib in High-grade Endometrial Cancer Trial Niraparib oral capsule - Endometrial Cancer, Serous Adenocarcinoma | Early Phase 1 | Withdrawn | Sir Mortimer B. Davis - Jewish General Hospital | 2024-05-01 | 2024-12-19 | |
| Efficacy of Platinum-based Chemotherapy in Platinum-resistant Ovarian Cancer) (EPITOC) Platinum-Based Drug, Conventional chemotherapy - Ovarian Cancer, Ovarian Neoplasms | Phase 2 / Phase 3 | Unknown | Blokhin's Russian Cancer Research Center | 164 | 2019-09-01 | 2019-08-13 |
Cystadenocarcinoma, Serous (2) · Endometrial Neoplasms (1) · Ovarian Neoplasms (1) · Uterine Neoplasms (1)
Adenocarcinoma (2) · Carcinoma (2) · Cystadenocarcinoma (2) · Female Urogenital Diseases (2) · Female Urogenital Diseases and Pregnancy Complications (2) · Genital Diseases (2) · Genital Diseases, Female (2) · Genital Neoplasms, Female (2) · Neoplasms (2) · Neoplasms by Histologic Type (2) · Neoplasms by Site (2) · Neoplasms, Cystic, Mucinous, and Serous (2) · Neoplasms, Glandular and Epithelial (2) · Urogenital Diseases (2) · Urogenital Neoplasms (2)
niraparib (1)
Blokhin's Russian Cancer Research Center (1) · Sir Mortimer B. Davis - Jewish General Hospital (1)
Russia (1)